We could not find any results for:
Make sure your spelling is correct or try broadening your search.
n By Andrea Figueras Shares in Sartorius tumbled Friday after the company downgraded its full-year targets and posted lower preliminary sales and earnings for the first nine months of 2023. At...
By Cecilia Butini Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA fell in opening trade on Friday after...
By Joshua Kirby Sartorius AG said Friday that it has reached a deal to buy French gene-therapy technology company Polyplus from a group of private investors for around 2.4 billion euros ($2.62...
Chiffre d’affaires de 1 076,7 millions d’euros (+18,1 %) ; prises de commandes de 1 147,1 millions d’euros (+ 18,0 %) ; marge d’EBITDA courant de 29,0 % Forte croissance dans toutes les...
Sales revenue up 19.3%; order intake up 18.7%; earnings margin 28.6%1) Growth across all product categories and geographies; the Americas particularly strong Guidance for 2019...
Regulatory News: At yesterday´s Annual General Shareholders' Meeting (AGM) of Sartorius Stedim Biotech S.A. (Paris:DIM) in Aubagne, France, shareholders passed the resolution to pay a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -17.7 | -9.67477452856 | 182.95 | 186.6 | 163.1 | 70038 | 171.26084605 | DE |
4 | -31.6 | -16.0528321057 | 196.85 | 197.05 | 163.1 | 63610 | 182.26158269 | DE |
12 | -14.8 | -8.21993890586 | 180.05 | 214.8 | 163.1 | 71104 | 184.39846099 | DE |
26 | -28.75 | -14.8195876289 | 194 | 214.8 | 139.1 | 82241 | 174.22588896 | DE |
52 | -34.55 | -17.2922922923 | 199.8 | 281 | 139.1 | 77112 | 200.4071269 | DE |
156 | -337.35 | -67.1209709511 | 502.6 | 544 | 139.1 | 60539 | 260.47981137 | DE |
260 | 28.65 | 20.9736456808 | 136.6 | 551 | 132.3 | 61097 | 271.45590343 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions